Interested in hearing our analysts speak on this subject? Complete the form below to request a recorded copy of the live webinar.

In the wake of the 2016 U.S. election, change is imminent for the healthcare system. But, how much change can be expected? A panel of DRG industry and policy experts have compiled an assessment of the potential impact of the 2016 election results for various parts of the U.S. healthcare system, and the implications for the pharmaceutical and medical technology industries. Download this analysis today to understand what to watch, and prepare for, as health policies shift over the next two-to-four years.

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now